about
Nutlin-3a, an MDM2 antagonist and p53 activator, helps to preserve the replicative potential of cancer cells treated with a genotoxic dose of resveratrolPolymorphisms in TDG and MGMT genes - epidemiological and functional study in lung cancer patients from PolandA functional analysis of G23A polymorphism and the alternative splicing in the expression of the XPA gene.Influence of DNA repair gene polymorphisms on prognosis in inoperable non-small cell lung cancer patients treated with radiotherapy and platinum-based chemotherapy.Truncating mutations of PPM1D are found in blood DNA samples of lung cancer patients.Meta- and pooled analysis of GSTP1 polymorphism and lung cancer: a HuGE-GSEC reviewA molecular epidemiology study in women from Upper Silesia, Poland.Single nucleotide polymorphisms in the 20q13 amplicon genes in relation to breast cancer risk and clinical outcome.Expression and localization of Werner syndrome protein is modulated by SIRT1 and PML.A novel germline TP53 mutation p.Pro190Arg detected in a patient with lung and bilateral breast cancers.The VEGFR2, COX-2 and MMP-2 polymorphisms are associated with clinical outcome of patients with inoperable non-small cell lung cancer.Metabolic gene polymorphisms and lung cancer risk in non-smokers. An update of the GSEC study.CYP1A1 T3801 C polymorphism and lung cancer: a pooled analysis of 2451 cases and 3358 controls.Polymorphisms in CYP1A1, GSTM1, GSTT1 and lung cancer below the age of 45 years.Association of metabolic gene polymorphisms with tobacco consumption in healthy controls.Influence of genetic polymorphisms on biomarkers of exposure and effects in children living in Upper Silesia.c-MYC Asn11Ser is associated with increased risk for familial breast cancer.Polymorphisms in the growth hormone receptor: a case-control study in breast cancer.Pharmacogenetics of toxicity of 5-fluorouracil, doxorubicin and cyclophosphamide chemotherapy in breast cancer patients.Specific combinations of DNA repair gene variants and increased risk for non-small cell lung cancer.Genetic polymorphisms in DNA repair genes and risk of lung cancer.Association of polymorphisms and haplotypes in the human growth hormone 1 (GH1) gene with breast cancer.Elevated risk of squamous-cell carcinoma of the lung in heavy smokers carrying the variant alleles of the TP53 Arg72Pro and p21 Ser31Arg polymorphismsInfluence of Polymorphisms in DNA Repair GenesXPD, XRCC1andMGMTon DNA Damage Induced by Gamma Radiation and its Repair in LymphocytesIn VitroBlood serum proteins as biomarkers for prediction of survival, locoregional control and distant metastasis rate in radiotherapy and radio-chemotherapy for non-small cell lung cancerThe effect of the genetic polymorphisms of CYP1A1,CYP2D6, GSTM1 and GSTP1 on aromatic DNA adduct levels in the population of healthy womenModulation of DNA adduct levels in human mononuclear white blood cells and granulocytes by CYP1A1 CYP2D6 and GSTM1 genetic polymorphismsThe SIPA1 -313A>G polymorphism is associated with prognosis in inoperable non-small cell lung cancerAssociation of Genetic Variants in ANGPT/TEK and VEGF/VEGFR with Progression and Survival in Head and Neck Squamous Cell Carcinoma Treated with Radiotherapy or Radiochemotherapy
P50
Q24595171-BC06BA39-8149-4B8D-B2F1-5C96B6DCAD4FQ28269221-A12B8CB1-E307-4619-BBEB-F30869C60678Q33701903-AAC90BC6-E1AD-496C-9B91-263044A0D66DQ34236406-5FA64278-52C6-492B-9A22-28B8D9E1769FQ35198383-B8822533-FD71-4EE4-9192-A14CAF37C111Q37306050-68FB6996-3A6A-42C7-9308-6F4C2EEA77E0Q39480103-58A6D5B3-A406-4186-9916-2D5CD361D2AAQ39743981-32949883-6037-4BB4-BD6A-766CD7601542Q40053325-8EA74E90-8304-426B-A229-1405EFD5358CQ40203543-96B7B873-0595-4897-B36B-360AF9747A20Q40939223-0EA63332-0068-4820-AD58-E270CFF06216Q44218297-B2E259C2-6039-49CF-AADA-AF71D83572BEQ44321042-0F0B5420-A235-4139-8006-52B40FB26DE0Q44399996-48982F39-4B84-4775-BCC3-A73C89092026Q44834254-A7E8CF87-8721-45A7-9E9C-8C1ABA023093Q45197958-1F08871C-A782-493E-B793-E91833EF7E5BQ46521646-D137D974-F54D-422E-B9E5-F90E258A2336Q46870627-670AB661-DA25-49B8-A170-9D8D294149A5Q51744122-4EB5647D-4906-43FF-818A-88E7613BE4D1Q53365544-15FE0210-1445-410B-A71F-56720D0F7A98Q53400095-B1D8B3E2-35BF-408E-AB73-2CA5397BB5E4Q53646165-B6AAF5EF-F732-4CB9-8693-F08E5A497F31Q59544921-3D1065F0-012F-46DD-9F88-77F990634CFEQ60656341-0880761E-ED75-4550-BB65-EC0AAF765D7CQ64061711-EE8B2968-55F2-4747-AA49-D2B8AEEB3C09Q74309093-DBEA6045-B454-4081-94FE-441FDAF40D50Q77120178-8E2E92F2-1A8C-40DB-A62E-1E6C65E2146BQ85887753-018C9546-DF35-4D14-8A1C-9C7C4947C364Q96294507-A34F745E-9EF9-4595-A265-E4E0E27C88F3
P50
description
researcher ORCID ID = 0000-0002-4043-3789
@en
wetenschapper
@nl
name
Dorota Butkiewicz
@ast
Dorota Butkiewicz
@en
Dorota Butkiewicz
@es
Dorota Butkiewicz
@nl
Dorota Butkiewicz
@pl
type
label
Dorota Butkiewicz
@ast
Dorota Butkiewicz
@en
Dorota Butkiewicz
@es
Dorota Butkiewicz
@nl
Dorota Butkiewicz
@pl
altLabel
Dorota Monika Butkiewicz
@pl
prefLabel
Dorota Butkiewicz
@ast
Dorota Butkiewicz
@en
Dorota Butkiewicz
@es
Dorota Butkiewicz
@nl
Dorota Butkiewicz
@pl
P106
P1153
56098582900
P31
P3124
P496
0000-0002-4043-3789